We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.


Medtronic offers medical products and therapies for the treatment of cardiac and vascular diseases, diabetes, and neu... read more Featured Products: More products

Download Mobile App

Chitosan Gel Technology Reduces Sinus Surgery Complications

By HospiMedica International staff writers
Posted on 29 Dec 2014
Print article
Medtronic\'s NovaShield injectable nasal packing and accordion cannula
The NovaShield injectable nasal packing and accordion cannula (Photo courtesy of Medtronic)
An injectable nasal packing helps control bleeding, adhesions, and infection following functional endoscopic sinus surgery (FESS).

The NovaShield Injectable Nasal Packing and Stent is made from chitosan, a polysaccharide derived from the shells of crustaceans, and is available in the form of an injectable, ready-to-use gel that is placed in the sinus or nasal cavities following FESS via an accordion cannula and flexible tip. The gel prevents adhesions by serving as space-occupying packing, promotes stenting of nasal structures (such as turbinates), controls minimal bleeding and oozing, and provides a level of antibacterial effectiveness by forming a barrier at the wound site.

In clinical studies the nasal packing demonstrated fast hemostasis with fewer adhesions, as well as a 95% success rate in the rapid control of nose-bleeding unresponsive to standard nasal packing, even in patients taking antiplatelet or anticoagulant therapy. The gel is also biofragmentable, and thus eliminates the painful packing removal associated with traditional sponge or gauze nasal packing. The NovaShield Injectable Nasal Packing and Stent is a product of Medtronic (Minneapolis, MN, USA), and has been approved by the US Food and Drug Administration (FDA).

“NovaShield is used to separate tissue and prevent adhesions by promoting stenting of nasal structures, such as the turbinates,” said Lisa Sapp, product manager for ENT Biomaterials at Medtronic. “With the benefits of chitosan and its unique design, NovaShield is helpful for both surgeons and patients.”

Chitosan is a linear polysaccharide polymer composed of randomly distributed glucoseamine deacetylated and acetylated units, and is produced by treating shrimp and other crustacean shells with the alkali sodium hydroxide (NaOH). Chitosan also has a number of commercial uses, such as a seed treatment and biopesticide, helping plants to fight off fungal infections. In winemaking it can be used as a fining agent, and it can also be used in self-healing polyurethane paint coating.

Related Links:

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Silver Member
Compact 14-Day Uninterrupted Holter ECG
Bronchoscopy Head Support
Reison 10-330
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
Click here to Register


Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.